| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/24/2015 | US8962650 Therapeutic agent for tumor |
| 02/24/2015 | US8962649 Multidose package, course and method of treatment for delivering predetermined multiple doses of a pharmaceutical |
| 02/24/2015 | US8962648 Tricyclic compounds and PBK inhibitors containing the same |
| 02/24/2015 | US8962647 Conjugate of polyethylene gylcol and naloxone and pharmaceutical composition and use thereof |
| 02/24/2015 | US8962646 Peripherally acting opioid compounds |
| 02/24/2015 | US8962644 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor |
| 02/24/2015 | US8962643 Compositions and methods for inhibition of the JAK pathway |
| 02/24/2015 | US8962642 5-cyano-4- (pyrrolo [2,3B] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 02/24/2015 | US8962641 Pyrimidine-substituted pyrrolidine derivatives, pharmaceutical compositions and uses thereof |
| 02/24/2015 | US8962640 Method for treating liver diseases of various origins |
| 02/24/2015 | US8962638 Piperidine inhibitors of janus kinase 3 |
| 02/24/2015 | US8962637 Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors |
| 02/24/2015 | US8962636 Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions |
| 02/24/2015 | US8962635 Tyrosine kinase inhibitors |
| 02/24/2015 | US8962634 4-amino-3-arylamino-6-arylpyrazolo[3,4-d) pyrimidine derivatives, methods for their preparation and their use as antiviral agents |
| 02/24/2015 | US8962633 Methods of treatment and prevention of metabolic bone diseases and disorders |
| 02/24/2015 | US8962632 Certain amino-pyrimidines, compositions thereof, and methods for their use |
| 02/24/2015 | US8962631 Compounds useful as inhibitors of ATR kinase |
| 02/24/2015 | US8962630 Pyrrolopyrimidine compounds and their uses |
| 02/24/2015 | US8962629 Tricyclic compounds |
| 02/24/2015 | US8962628 Herbicidal 5H-quinoxaline-6-one derivatives detailed description |
| 02/24/2015 | US8962627 Oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors |
| 02/24/2015 | US8962626 Thienopyridazine compounds, their preparations, pharmaceutical compositions and uses |
| 02/24/2015 | US8962625 Pyridazinone compound and use thereof |
| 02/24/2015 | US8962624 Morpholines as selective inhibitors of cytochrome P450 2A13 |
| 02/24/2015 | US8962623 Aminopyrazine compounds |
| 02/24/2015 | US8962622 Benzotriazole kinase modulators |
| 02/24/2015 | US8962620 Substituted 6,5-fused bicyclic heteroaryl compounds |
| 02/24/2015 | US8962619 Substituted imidazopyridinyl-aminopyridine compounds |
| 02/24/2015 | US8962618 Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof |
| 02/24/2015 | US8962617 Use of dihydroimidazolones for the treatment of dogs |
| 02/24/2015 | US8962616 Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds |
| 02/24/2015 | US8962615 Cell migration modulating compounds |
| 02/24/2015 | US8962614 ON01910.Na enhances chemotherapeutic agent activity in drug-resistant tumors |
| 02/24/2015 | US8962613 P2X4 receptor antagonist |
| 02/24/2015 | US8962612 Tetrahydroisoquinoline derivative |
| 02/24/2015 | US8962611 Substituted imidazopyridines as HDM2 inhibitors |
| 02/24/2015 | US8962610 Fused heterocyclic compounds as ion channel modulators |
| 02/24/2015 | US8962609 Pyrimidine compounds as inhibitors of protein kinases IKK epsilon and/or TBK-1, processes for their preparation, and pharmaceutical compositions containing them |
| 02/24/2015 | US8962608 Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors |
| 02/24/2015 | US8962607 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 02/24/2015 | US8962606 Substituted benzosulphonamides |
| 02/24/2015 | US8962604 Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
| 02/24/2015 | US8962603 Method for post coital contraception in overweight or obese female subjects using ulipristal acetate |
| 02/24/2015 | US8962602 Anticancer steroidal lactones unsaturated in position 7 (8) |
| 02/24/2015 | US8962601 Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids |
| 02/24/2015 | US8962600 Neuroprotective compounds and their use |
| 02/24/2015 | US8962599 Therapeutic compositions comprising imidazole and imidazolium compounds |
| 02/24/2015 | US8962598 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as AHR activators |
| 02/24/2015 | US8962596 5,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinases |
| 02/24/2015 | US8962595 Compositions of small molecule therapeutics |
| 02/24/2015 | US8962594 Method of using nutritional compounds dihydroquercetin (taxifolin) and arabinogalactan in combination with dihydroquercetin (taxifolin) to reduce and control cardiometabolic risk factors associated with metabolic syndrome and hypercholesterolemia |
| 02/24/2015 | US8962593 GLA monotherapy for use in cancer treatment |
| 02/24/2015 | US8962592 Methods of treating a meiotic kinesin associated disease |
| 02/24/2015 | US8962590 Prostate cancer vaccine |
| 02/24/2015 | US8962587 Gene delivery of OCT4 and SirT1 and pharmaceutical compositions thereof |
| 02/24/2015 | US8962585 Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63 |
| 02/24/2015 | US8962584 Compositions for controlling Varroa mites in bees |
| 02/24/2015 | US8962583 Treatment of inflammatory diseases using miR-124 |
| 02/24/2015 | US8962579 Methods and compositions for inhibition of immune responses and autoimmunity |
| 02/24/2015 | US8962578 Fungicidal active substance combinations |
| 02/24/2015 | US8962577 Controlled release formulations for the delivery of HIF-1 inhibitors |
| 02/24/2015 | US8962576 Compositions and method for improving endothelial function and cardiovascular health |
| 02/24/2015 | US8962575 Clerodane derivatives for modulation of leukotriene receptor activity and related diseases |
| 02/24/2015 | US8962574 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy |
| 02/24/2015 | US8962573 Compounds targeting the cation-independent mannose 6-phosphate receptor |
| 02/24/2015 | US8962572 Bortezomib formulations |
| 02/24/2015 | US8962568 Treatment of T-cell mediated diseases |
| 02/24/2015 | US8962558 Methods for reducing GnRH-positive tumor cell proliferation using the GnRH antagonist IN3 |
| 02/24/2015 | US8962554 Oral insulin therapies and protocol |
| 02/24/2015 | US8962549 Polymeric benzyl carbonate-derivatives |
| 02/24/2015 | US8962547 Compositions comprising enzyme-cleavable oxycodone prodrug |
| 02/24/2015 | US8962546 Modulation of estrogen receptor-related receptor gamma (ERRγ) and uses therefor |
| 02/24/2015 | US8962545 Enzyme treatment of foodstuffs for celiac sprue |
| 02/24/2015 | US8962530 Inflammatory bowel disease therapies |
| 02/24/2015 | US8962329 Gene cluster |
| 02/24/2015 | US8962244 Compounds for modulating RNA binding proteins and uses therefor |
| 02/24/2015 | US8962239 Methods useful for vitamin D deficiency and related disorders |
| 02/24/2015 | US8962063 Methods and systems for dosing and coating inhalation powders onto carrier particles |
| 02/24/2015 | US8962045 Herbal/organic composition for the management of pain |
| 02/24/2015 | US8962043 Visual performance and/or macular pigmentation |
| 02/24/2015 | US8962039 Method of treatment of neurodegenerative or neuro-muscular degenerative diseases and therapeutic agent to treat the same |
| 02/24/2015 | US8962038 Nitrite formulations and their use as nitric oxide prodrugs |
| 02/24/2015 | US8962032 Modulator |
| 02/24/2015 | US8962030 Nanoparticles for delivery of active agents |
| 02/24/2015 | US8962027 Materials comprising water-soluble polymer particles and methods of making and using them |
| 02/24/2015 | US8962024 Method for treating primary insomnia |
| 02/24/2015 | US8962023 UV cured gel and method of making |
| 02/24/2015 | US8962022 Pharmaceutical compositions comprising an active substance from the substituted benzhydrylpiperazine family |
| 02/24/2015 | US8962021 Solid pharmaceutical composition comprising telithromycin |
| 02/24/2015 | US8962020 Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid |
| 02/24/2015 | US8962019 Sustained drug release composition |
| 02/24/2015 | US8962018 Oral formulation of anhydrous olanzapine form I |
| 02/24/2015 | US8962017 Formulation of silymarin with high efficacy and prolonged action and the preparation method thereof |
| 02/24/2015 | US8962016 Extended release dosage forms of metoprolol |
| 02/24/2015 | US8962014 Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
| 02/24/2015 | US8962013 Multi-layered transdermal system with triazine UV absorber |
| 02/24/2015 | US8962010 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 02/24/2015 | US8962009 Sustained release intraocular implants and related methods |
| 02/24/2015 | US8962007 Method of improving absorption of vitamin E by a pet animal |